Abstract
Roles of nuclear medicine and molecular imaging in cancer diagnosis and therapy are constantly evolving. Single-photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging allows the investigation of not only morphological but also functional characteristics of tumor tissues and possess distinct advantageous characteristics, such as high specificity and sensitivity, excellent quantifiability and virtually no tissue penetration limit. Nanoparticles, as multifunctional materials, hold the potential of being surface-engineered, conjugated to numerous targeting agents while carrying therapeutic or diagnostic agents and, thus, can provide the platforms needed for enhancing imaging and therapy efficacy and specificity; hence a large number of nanocarriers have been radiolabeled with a vast array of SPECT and PET agents for preclinical studies. In this context, radiolabeled nanoparticles hold the potential to deeply impact the science of clinical practice, from disease diagnosis to patient management. This chapter provides a comprehensive overview of the methods of synthesis, radiolabeling and further applications of the most commonly used nanoparticles in radionanomedicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
S. Same, A. Aghanejad, S. Akbari Nakhjavani, J. Barar, Y. Omidi, Radiolabeled theranostics: magnetic and gold nanoparticles. Bioimpacts 6, 169–181 (2016)
G. Ting, C.H. Chang, H.E. Wang, T.W. Lee, Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy. J. Biomed. Biotechnol. (2010)
S.M. Moghimi, A.C. Hunter, J.C. Murray, Nanomedicine: current status and future prospects. FASEB J. 19, 311–330 (2005)
V. Mailander, K. Landfester, Interaction of nanoparticles with cells. Biomacromol 10, 2379–2400 (2009)
C. Fang, M. Zhang, Multifunctional magnetic nanoparticles for medical imaging applications. J. Mater. Chem. 19, 6258–6266 (2009)
A.B. de Barros, A. Tsourkas, B. Saboury, V.N. Cardoso, A. Alavi, Emerging role of radiolabeled nanoparticles as an effective diagnostic technique. EJNMMI Res. 2, 39 (2012)
S. Parveen, R. Misra, S.K. Sahoo, Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 8, 147–166 (2012)
H. Nehoff, N.N. Parayath, L. Domanovitch, S. Taurin, K. Greish, Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect. Int. J. Nanomed. 9, 2539–2555 (2014)
S.L. Bellis, Biomaterials Advantages of RGD peptides for directing cell association with biomaterials. Biomaterials 32, 4205–4210 (2011)
A.L. de Barros, L.G. das Mota, C.A. de Ferreira, M.C. de Oliveira, A.M. de Goes, Cardoso VN. Bombesin derivative radiolabeled with technetium-99 m as agent for tumor identification. Bioorg. Med. Chem. Lett. 20, 6182–6184
A.L. Daugherty, R.J. Mrsny, Formulation and delivery issues for monoclonal antibody therapeutics. Adv. Drug Deliv. Rev. 58, 686–706 (2006)
A. Garcia-Bennett, M. Nees, B. Fadeel, In search of the holy grail: Folate-targeted nanoparticles for cancer therapy. Biochem. Pharmacol. 81, 976–984 (2011)
J.H. Lee, M.V. Yigit, D. Mazumdar, Y. Lu, Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates. Adv. Drug Deliv. Rev. 62, 592–605 (2010)
K. Knop, R. Hoogenboom, D. Fischer, U.S. Schubert, Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. Engl. 49, 6288–6308 (2010)
J.V. Jokerst, T. Lobovkina, R.N. Zare, S.S. Gambhir, Nanoparticle PEGylation for imaging and therapy. Nanomedicine (London) 6, 715–728 (2011)
S. Goel, C.G. England, F. Chen, W. Cai, Positron emission tomography and nanotechnology: a dynamic duo for cancer theranostics. Adv. Drug Deliv. Rev. 113, 157–176 (2016)
D. Sarko, M. Eisenhut, U. Haberkorn, W. Mier, Bifunctional chelators in the design and application of radiopharmaceuticals for oncological diseases. Curr. Med. Chem. 19, 2667–2688 (2012)
M. Sun, D. Hoffman, G. Sundaresan, L. Yang, N. Lamichhane, J. Zweit, Synthesis and characterization of intrinsically radiolabeled quantum dots for bimodal detection. Am. J. Nucl. Med. Mol. Imaging 2, 122–135 (2012)
S. Goel, F. Chen, E.B. Ehlerding, W. Cai, Intrinsically radiolabeled nanoparticles: an emerging paradigm. Small 10, 3825–3830 (2014)
W. Cai, H. Hong, In a “nutshell”: intrinsically radio-labeled quantum dots. Am. J. Nucl. Med. Mol. Imaging 2, 136–140 (2012)
S. Goel, F. Chen, S. Luan, H.F. Valdovinos, S. Shi, S.A. Graves et al., Engineering intrinsically zirconium-89 radiolabeled self-destructing mesoporous silica nanostructures for in vivo biodistribution and tumor targeting studies. Adv. Sci. 3, 1600122 (2016)
H.Y. Yoon, S. Jeon, D.G. You, J.H. Park, I.C. Kwon, H. Koo et al., Inorganic nanoparticles for image-guided therapy. Bioconjug. Chem. 28(1), 124–134 (2017)
J. Conde, J.T. Dias, V. Grazú, M. Moros, P.V. Baptista, J.M. de la Fuente, Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine. Front. Chem. 2, 48 (2014)
M. Longmire, P.L. Choyke, H. Kobayashi, Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (London) 3, 703–717 (2008)
T.F. Massoud, S.S. Gambhir, Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17, 545–580 (2003)
V.I. Shubayev, T.R. Pisanic 2nd, S. Jin, Magnetic nanoparticles for theragnostics. Adv. Drug Deliv. Rev. 61, 467–477 (2009)
Y. Xing, J. Zhao, P.S. Conti, K. Chen, Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics 4(3), 290–306 (2014)
P. Bouziotis, D. Psimadas, T. Tsotakos, D. Stamopoulos, C. Tsoukalas, Radiolabeled iron oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents. Curr. Top. Med. Chem. 12, 2694–2702 (2012)
Y.-X.J. Wang, Superparamagnetic iron oxide based MRI contrast agents: Curr. Status Clin Appl. Quant Imaging Med. Surg. 1, 35–40 (2011)
M.G. Harisinghani, J. Barentsz, P.F. Hahn, W.M. Deserno, S. Tabatabaei, C.H. van de Kaa et al., Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 348, 2491–2499 (2003)
F.M. Kievit, M. Zhang, Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc. Chem. Res. 44, 853–862 (2011)
M.S. Judenhofer, H.F. Wehrl, D.F. Newport, C. Catana, S.B. Siegel, M. Becker et al., Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat. Med. 14, 459–465 (2008)
F. Ai, C.A. Ferreira, F. Chen, W. Cai, Engineering of radiolabeled iron oxide nanoparticles for dual-modality imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 8(4), 619–630 (2016)
M.S. Judenhofer, S.R. Cherry, Applications for preclinical PET/MRI. Semin. Nucl. Med. 43, 19–29 (2013)
H. Zaidi, A. Del Guerra, An outlook on future design of hybrid PET/MRI systems. Med. Phys. 38, 5667–5689 (2011)
R. Madru, P. Kjellman, F. Olsson, K. Wingardh, C. Ingvar, F. Stahlberg et al., 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes. J. Nucl. Med. 53, 459–463 (2012)
Y. Tang, C. Zhang, J. Wang, X. Lin, L. Zhang, Y. Yang et al., MRI/SPECT/Fluorescent tri-Modal probe for evaluating the homing and therapeutic efficacy of transplanted mesenchymal stem cells in a rat ischemic stroke model. Adv. Funct. Mater. 25, 1024–1034 (2015)
J. Chen, S. Zhu, L. Tong, J. Li, F. Chen, Y. Han et al., Superparamagnetic iron oxide nanoparticles mediated 131I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice. BMC Cancer 14, 114 (2014)
S.I. Park, B.J. Kwon, J.H. Park, H. Jung, K.H. Yu, Synthesis and characterization of 3-[131I]iodo-L-tyrosine grafted Fe3O4@SiO2 nanocomposite for single photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI). J. Nanosci. Nanotechnol. 11, 1818–1821 (2011)
H. Zolata, F. Abbasi Davani, H. Afarideh, Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles. Nucl. Med. Biol. 42, 164–170 (2015)
H. Wang, R. Kumar, D. Nagesha, R.I. Duclos, S. Sridhar, S.J. Gatley, Integrity of 111In-radiolabeled superparamagnetic iron oxide nanoparticles in the mouse. Nucl. Med. Biol. 42, 65–70 (2015)
J. Cao, Y. Wang, J. Yu, J. Xia, C. Zhang, D. Yin et al., Preparation and radiolabeling of surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy. J. Magn. Mater. 277, 165–174 (2004)
R. Thomas, I.-K. Park, Y. Jeong, Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer. Int. J. Mol. Sci. 14, 15910–15930 (2013)
B.R. Jarrett, B. Gustafsson, D.L. Kukis, A.Y. Louie, Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging. Bioconjug. Chem. 19, 1496–1504 (2008)
X. Yang, H. Hong, J.J. Grailer, I.J. Rowland, A. Javadi, S.A. Hurley et al., cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 32, 4151–4160 (2011)
R.T.M. de Rosales, R. Tavaré, R.L. Paul, M. Jauregui-Osoro, A. Protti, A. Glaria et al., Synthesis of 64Cu(II)–Bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: In vivo evaluation as dual-modality PET–MRI agent. Angew. Chem. Int. Ed. Engl. 50, 5509–5513 (2011)
S. Kim, M.K. Chae, M.S. Yim, I.H. Jeong, J. Cho, C. Lee et al., Hybrid PET/MR imaging of tumors using an oleanolic acid-conjugated nanoparticle. Biomaterials 34, 8114–8121 (2013)
N.K. Devaraj, E.J. Keliher, G.M. Thurber, M. Nahrendorf, R. Weissleder, 18F labeled nanoparticles for in vivo PET-CT imaging. Bioconjug. Chem. 20, 397–401 (2009)
E. Boros, A.M. Bowen, L. Josephson, N. Vasdev, J.P. Holland, Chelate-free metal ion binding and heat-induced radiolabeling of iron oxide nanoparticles. Chem Sci. 6, 225–236 (2015)
R. Chakravarty, H.F. Valdovinos, F. Chen, C.M. Lewis, P.A. Ellison, H. Luo et al., Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo dual-modality PET/MR zimaging. Adv. Mater. 26, 5119–5123 (2014)
X. Cui, S. Belo, D. Kruger, Y. Yan, R.T.M. de Rosales, M. Jauregui-Osoro et al., Aluminium hydroxide stabilised MnFe2O4 and Fe3O4 nanoparticles as dual-modality contrasts agent for MRI and PET imaging. Biomaterials 35, 5840–5846 (2014)
F. Chen, P.A. Ellison, C.M. Lewis, H. Hong, Y. Zhang, S. Shi et al., Chelator-free synthesis of a dual-modality PET/MRI agent. Angew. Chem. Int. Ed. Engl. 52, 13319–13323 (2013)
R.A. Sperling, P. Rivera Gil, F. Zhang, M. Zanella, W.J. Parak, Biological applications of gold nanoparticles. Chem. Soc. Rev. 37, 1896–1908 (2008)
W. Cai, T. Gao, H. Hong, J. Sun, Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol. Sci. Appl. 1, 17–32 (2008)
J. Turkevich, P.C. Stevenson, J. Hillier, A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss. Faraday Soc. 11, 55–75 (1951)
N. Khlebtsov, L. Dykman, Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev. 40, 1647–1671 (2011)
D. Goia, E. Matijević, Tailoring the particle size of monodispersed colloidal gold. Colloids Surf. Physicochem. Eng. Asp. 146, 139–152 (1999)
R. Herizchi, E. Abbasi, M. Milani, A. Akbarzadeh, Current methods for synthesis of gold nanoparticles. Artif. Cells Nanomed. Biotechnol. 44, 596–602 (2016)
C.J. Murphy, A.M. Gole, J.W. Stone, P.N. Sisco, A.M. Alkilany, E.C. Goldsmith et al., Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc. Chem. Res. 41, 1721–1730 (2008)
S. Mallidi, T. Larson, J. Aaron, K. Sokolov, S. Emelianov, Molecular specific optoacoustic imaging with plasmonic nanoparticles. Opt. Express 15, 6583–6588 (2007)
J.K. Young, E.R. Figueroa, R.A. Drezek, Tunable nanostructures as photothermal theranostic agents. Ann. Biomed. Eng. 40, 438–459 (2012)
X. Huang, M.A. El-Sayed, Gold nanoparticles: Optical properties and implementations in cancer diagnosis and photothermal therapy. J. Adv. Res. 1, 13–28 (2010)
X. Huang, P.K. Jain, I.H. El-Sayed, M.A. El-Sayed, Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med. Sci. 23, 217 (2007)
N. Zhao, Y. Pan, Z. Cheng, H. Liu, Gold nanoparticles for cancer theranostics: a brief update. J. Innov. Opt. Health Sci. 9, 1–10 (2016)
M. Das, K.H. Shim, S.S.A. An, D.K. Yi, Review on gold nanoparticles and their applications. Toxicol. Environ. Health Sci. 3, 193–205 (2011)
B.E. Ocampo-García, F.M. de Ramírez, G. Ferro-Flores, L.M. De León-Rodríguez, C.L. Santos-Cuevas, E. Morales-Avila et al., 99mTc-labeled gold nanoparticles capped with HYNIC-peptide/mannose for sentinel lymph node detection. Nucl. Med. Biol. 38, 1–11 (2011)
Y. Xing, J. Zhao, X. Shi, P.S. Conti, K. Chen, Recent development of radiolabeled nanoparticles for PET imaging. Austin J. Nanomed. Nanotechnol. 2, 1016 (2014)
H. Xie, Z.J. Wang, A. Bao, B. Goins, W.T. Phillips, In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts. Int. J. Pharm. 395, 324–330 (2010)
F. Chen, S. Goel, R. Hernandez, S.A. Graves, S. Shi, R.J. Nickles et al., Dynamic positron emission tomography imaging of renal clearable gold nanoparticles. Small 12, 2775–2782 (2016)
C. Zhou, G. Hao, P. Thomas, J. Liu, M. Yu, S. Sun et al., Near-infrared emitting radioactive gold nanoparticles with molecular pharmacokinetics. Angew. Chem. Int. Ed. Engl. 51, 10118–10122 (2012)
L. Karmani, D. Labar, V. Valembois, V. Bouchat, P.G. Nagaswaran, A. Bol et al., Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice. Contrast Media Mol. Imaging 8, 402–408 (2013)
T. Aweda, D. Sultan, Y. Liu, Radio-labeled nanoparticles for biomedical imaging, in Nanotechnology for Biomedical Imaging and Diagnostics, ed. by Y. Mikhail (Wiley, New York, 2014), pp. 193–221
Y. Zhao, D. Sultan, L. Detering, S. Cho, G. Sun, R. Pierce et al., Copper-64-alloyed gold nanoparticles for cancer imaging: Improved radiolabel stability and diagnostic accuracy. Angew. Chem. Int. Ed. Engl. 53, 156–159 (2014)
J. Lipka, M. Semmler-Behnke, R.A. Sperling, A. Wenk, S. Takenaka, C. Schleh et al., Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 31, 6574–6581 (2010)
L. Sun, D. Liu, Z. Wang, Functional gold nanoparticle − peptide Complexes as cell-targeting agents. Langmuir 24, 10293–10297 (2008)
D.J. Javier, N. Nitin, M. Levy, A. Ellington, R. Richards-Kortum, Aptamer-targeted gold nanoparticles as molecular-specific contrast agents for reflectance imaging. Bioconjug. Chem. 19, 1309–1312 (2008)
D.A. Giljohann, D.S. Seferos, A.E. Prigodich, P.C. Patel, C.A. Mirkin, Gene regulation with polyvalent siRNA-nanoparticle conjugates. J. Am. Chem. Soc. 131, 2072–2073 (2009)
R. Marega, L. Karmani, L. Flamant, P.G. Nageswaran, V. Valembois, B. Masereel et al., Antibody-functionalized polymer-coated gold nanoparticles targeting cancer cells: an in vitro and in vivo study. J. Mater. Chem. 22, 21305–21312 (2012)
P.M. Tiwari, K. Vig, V. Dennis, S.R. Singh, Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 1, 31–63
E. Sadauskas, G. Danscher, M. Stoltenberg, U. Vogel, A. Larsen, H. Wallin, Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine 5, 162–169 (2009)
W.-S. Cho, M. Cho, J. Jeong, M. Choi, H.-Y. Cho, B.S. Han et al., Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 236, 16–24 (2009)
J.F. Dorsey, L. Sun, D.Y. Joh, A. Witztum, G.D. Kao, M. Alonso-Basanta et al., Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization. Transl. Cancer Res. 2, 280–291 (2013)
X. Gao, L. Yang, J.A. Petros, F.F. Marshall, J.W. Simons, S. Nie, In vivo molecular and cellular imaging with quantum dots. Curr. Opin. Biotechnol. 16, 63–72 (2005)
W.C.W. Chan, D.J. Maxwell, X. Gao, R.E. Bailey, M. Han, S. Nie, Luminescent quantum dots for multiplexed biological detection and imaging. Curr. Opin. Biotechnol. 13, 40–46 (2002)
Y. Ghasemi, P. Peymani, S. Afifi, Quantum dot: magic nanoparticle for imaging, detection and targeting. Acta Biomed. 80, 156–165 (2009)
M.J. Bruchez, M. Moronne, P. Gin, S. Weiss, A.P. Alivisatos, Semiconductor nanocrystals as fluorescent biological labels. Science 281, 2013–2016 (1998)
K.-H. Lee, Quantum dots: a quantum jump for molecular imaging? J. Nucl. Med. 48, 1408–1410 (2007)
L.A. Bentolila, X. Michalet, F.F. Pinaud, J.M. Tsay, S. Doose, J.J. Li et al., Quantum dots for molecular imaging and cancer medicine. Discov. Med. 5, 213–218 (2005)
J.K. Jaiswal, H. Mattoussi, J.M. Mauro, S.M. Simon, Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol. 21, 47–51 (2003)
I.L. Medintz, H.T. Uyeda, E.R. Goldman, H. Mattoussi, Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 4, 435–446 (2005)
X. Peng, J. Wickham, A.P. Alivisatos, Kinetics of II-VI and III-V colloidal semiconductor nanocrystal growth: “Focusing” of size distributions. J. Am. Chem. Soc. 120, 5343–5344 (1998)
X. Peng, L. Manna, W. Yang, J. Wickham, E. Scher, A. Kadavanich et al., Shape control of CdSe nanocrystals. Nature 404, 59–61 (2000)
H.-C. Huang, S. Barua, G. Sharma, S.K. Dey, K. Rege, Inorganic nanoparticles for cancer imaging and therapy. J. Control Release 155, 344–357 (2011)
S. Jin, Y. Hu, Z. Gu, L. Liu, H.-C. Wu, Application of quantum dots in biological imaging. J. Nanomater. 2011, 1–13 (2011)
P. Pericleous, M. Gazouli, A. Lyberopoulou, S. Rizos, N. Nikiteas, E.P. Efstathopoulos, Quantum dots hold promise for early cancer imaging and detection. Int. J. Cancer 131, 519–528 (2012)
M. Fang, C.-W. Peng, D.-W. Pang, Y. Li, Quantum dots for cancer research: current status, remaining issues, and future perspectives. Cancer Biol. Med. 9, 151–163 (2012)
H. Zhang, D. Yee, C. Wang, Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine (London) 3, 83–91 (2008)
Y. Zhu, H. Hong, Z.P. Xu, Z. Li, W. Cai, Quantum dot-based nanoprobes for in vivo targeted imaging. Curr. Mol. Med. 13, 1549–1567 (2013)
R. Dey, S. Mazumder, M.K. Mitra, S. Mukherjee, G.C. Das, Review: Biofunctionalized quantum dots in biology and medicine. J. Nanomater. 2009, 1–17 (2009)
M. Felber, M. Bauwens, J.M. Mateos, S. Imstepf, F.M. Mottaghy, R. Alberto, 99mTc radiolabeling and biological evaluation of nanoparticles functionalized with a versatile coating ligand. Chemistry 21, 6090–6099 (2015)
J.J. Park, T.S. Lee, J.H. Kang, E.J. Kim, R.J. Yoo, G.S. Woo et al., SPECT/CT imaging of radiolabeled quantum dots, in Proceedings of KNS Autumn Meet (2010), pp. 793–794
S. Yang, S. Goel, W. Cai, In vivo molecular imaging with quantum dots: toward multimodality and theranostics, in Biological and Pharmaceutical Applications of Nanomaterials, ed. by P. Prokopovich (CRC Press, New York, 2015), pp. 319–346
W. Cai, K. Chen, Z.-B. Li, S.S. Gambhir, X. Chen, Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J. Nucl. Med. 48, 1862–1870 (2007)
F. Ducongé, T. Pons, C. Pestourie, L. Hérin, B. Thézé, K. Gombert et al., Fluorine-18-labeled phospholipid quantum dot micelles for in vivo multimodal imaging from whole body to cellular scales. Bioconjug. Chem. 19, 1921–1926 (2008)
K. Chen, Z.-B. Li, H. Wang, W. Cai, X. Chen, Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots. Eur. J. Nucl. Med. Mol. Imaging 35, 2235–2244 (2008)
C. Tu, X. Ma, A. House, S.M. Kauzlarich, A.Y. Louie, PET imaging and biodistribution of silicon quantum dots in mice. ACS Med. Chem. Lett. 2, 285–288 (2011)
K. Hu, H. Wang, G. Tang, T. Huang, X. Tang, X. Liang et al., In vivo cancer dual-targeting and dual-modality imaging with functionalized quantum dots. J. Nucl. Med. 56, 1278–1284 (2015)
M.L. Schipper, G. Iyer, A.L. Koh, Z. Cheng, Y. Ebenstein, A. Aharoni et al., Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 5, 126–134 (2009)
M.L. Schipper, Z. Cheng, S.-W. Lee, L.A. Bentolila, G. Iyer, J. Rao et al., microPET-based biodistribution of quantum dots in living mice. J. Nucl. Med. 48, 1511–1518 (2007)
X. Sun, X. Huang, J. Guo, W. Zhu, Y. Ding, G. Niu et al., Self-illuminating 64Cu-doped CdSe/ZnS nanocrystals for in vivo tumor imaging. J. Am. Chem. Soc. 136, 1706–1709 (2014)
S.J. Kennel, J.D. Woodward, A.J. Rondinone, J. Wall, Y. Huang, S. Mirzadeh, The fate of MAb-targeted Cd125mTe/ZnS nanoparticles in vivo. Nucl. Med. Biol. 35, 501–514 (2008)
S.J. Kennel, J.D. Woodward, A.J. Rondinone, J. Wall, Y. Huang, S. Mirzadeh, The fate of MAb-targeted Cd125mTe/ZnS nanoparticles in vivo. Nucl. Med. Biol. 35, 501–514 (2008)
H.S. Choi, W. Liu, P. Misra, E. Tanaka, J.P. Zimmer, B.I. Ipe et al., Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165–1170 (2007)
M. Vallet-Regi, A. Rámila, R.P. del Real, J. Pérez-Pariente, A new property of MCM-41: drug delivery system. Chem. Mater. 13, 308–311 (2001)
D.M. Coldwell, A.S. Kennedy, C.W. Nutting, Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 69, 800–804 (2007)
R. Salem, R.J. Lewandowski, B. Atassi, S.C. Gordon, V.L. Gates, O. Barakat et al., Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J. Vasc. Interv. Radiol. 16, 1627–1639 (2005)
R.J. Lewandowski, K.G. Thurston, J.E. Goin, C.O. Wong, V.L. Gates, Buskirk M. Van et al., 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: Response to treatment at targeted doses of 135–150 Gy as Measured by [18F] Fluorodeoxyglucose positron emission tomography and Computed Tomographic Imaging. J. Vasc. Interv. Radiol. 16, 1641–1651 (2005)
M. Benezra, O. Penate-medina, P.B. Zanzonico, D. Schaer, H. Ow, A. Burns et al., Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J. Clin. Invest. 121, 2768–2780 (2011)
E. Phillips, O. Penate-Medina, P.B. Zanzonico, R.D. Carvajal, P. Mohan, Y. Ye et al., Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci. Transl. Med. 6, 260ra149 (2014)
I.I. Slowing, J.L. Vivero-Escoto, C.-W. Wu, Lin VS-Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 60, 1278–1288 (2008)
A. Liberman, N. Mendez, W.C. Trogler, A.C. Kummel, Synthesis and surface functionalization of silica nanoparticles for nanomedicine. Surf. Sci. Rep. 69, 132–158 (2014)
K. Zarschler, L. Rocks, N. Licciardello, L. Boselli, E. Polo, K.P. Garcia et al., Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications. Nanomedicine 12, 1663–1701 (2016)
E.B. Ehlerding, F. Chen, W. Cai, Biodegradable and renal clearable inorganic nanoparticles. Adv. Sci. (Weinh) 3 (2016)
J.L. Vivero-Escoto, R.C. Huxford-Phillips, W. Lin, Silica-based nanoprobes for biomedical imaging and theranostic applications. Chem. Soc. Rev. 41, 2673–2685 (2012)
B.G. Trewyn, I.I. Slowing, S. Giri, H.-T. Chen, V.S.-Y. Lin, Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc. Chem. Res. 40, 846–853 (2007)
C. Barbé, J. Bartlett, L. Kong, K. Finnie, H.Q. Lin, M. Larkin et al., Silica particles: a novel drug-delivery system. Adv. Mater. 16, 1959–1966 (2004)
R. Kumar, I. Roy, T.Y. Ohulchanskky, L.A. Vathy, E.J. Bergey, M. Sajjad et al., In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 4, 699–708 (2010)
L. Tang, X. Yang, L.W. Dobrucki, I. Chaudhury, Q. Yin, C. Yao et al., Aptamer-functionalized, ultra-small, monodisperse silica nanoconjugates for targeted dual-modal imaging of lymph nodes with metastatictTumors. Angew. Chem. Int. Ed. Engl. 51, 12721–12726 (2012)
F. Chen, H. Hong, S. Shi, S. Goel, H.F. Valdovinos, R. Hernandez et al., Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy. Sci Rep. 4, 5080 (2014)
T.M. Shaffer, M.A. Wall, S. Harmsen, V.A. Longo, C.M. Drain, M.F. Kircher et al., Silica nanoparticles as substrates for chelator-free labeling of oxophilic radioisotopes. Nano Lett. 15, 864–868 (2015)
F. Chen, S. Goel, H.F. Valdovinos, H. Luo, R. Hernandez, T.E. Barnhart et al., In vivo integrity and biological fate of chelator-free zirconium-89-labeled mesoporous silica nanoparticles. ACS Nano 9, 7950–7959 (2015)
L. Tang, J. Cheng, Nonporous silica nanoparticles for nanomedicine application. Nano Today 8, 290–312 (2013)
S. Shi, F. Chen, W. Cai, Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging. Nanomedicine (London) 8, 2027–2039 (2013)
R. Alshehri, A.M. Ilyas, A. Hasan, A. Arnaout, F. Ahmed, A. Memic, Carbon nanotubes in biomedical applications: factors, mechanisms, and remedies of toxicity. J. Med. Chem. 59, 8149–8167 (2016)
W. Yang, P. Thordarson, J.J. Gooding, S.P. Ringer, F. Braet, Carbon nanotubes for biological and biomedical applications. Nanotechnology 18, 412001 (2007)
H. Gong, R. Peng, Z. Liu, Carbon nanotubes for biomedical imaging: the recent advances. Adv. Drug Deliv. Rev. 65, 1951–1963 (2013)
H. Wang, J. Wang, X. Deng, H. Sun, Z. Shi, Z. Gu et al., Biodistribution of carbon single-wall carbon nanotubes in mice. J. Nanosci. Nanotechnol. 4, 1019–1024 (2004)
X. Deng, S. Yang, H. Nie, H. Wang, Y. Liu, A generally adoptable radiotracing method for tracking carbon nanotubes in animals. Nanotechnology 19, 75101 (2008)
L. Lacerda, A. Soundararajan, R. Singh, G. Pastorin, K.T. Al-Jamal, J. Turton et al., Dynamic imaging of functionalized multi-walled carbon nanotube systemic circulation and urinary vxcretion. Adv. Mater. 20, 225–230 (2008)
J. Guo, X. Zhang, Q. Li, W. Li, Biodistribution of functionalized multiwall carbon nanotubes in mice. Nucl. Med. Biol. 34, 579–583 (2007)
M.R. McDevitt, D. Chattopadhyay, J.S. Jaggi, R.D. Finn, P.B. Zanzonico, C. Villa et al., PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice. PLoS ONE 2, e907 (2007)
Z. Liu, W. Cai, L. He, N. Nakayama, K. Chen, X. Sun et al., In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2, 47–52 (2007)
B. Czarny, D. Georgin, F. Berthon, G. Plastow, M. Pinault, G. Patriarche et al., Carbon nanotube translocation to distant organs after pulmonary exposure: insights from in situ 14C-radiolabeling and tissue radioimaging. ACS Nano 8, 5715–5724 (2014)
M.L. Matson, C.H. Villa, J.S. Ananta, J.J. Law, D.A. Scheinberg, L.J. Wilson, Encapsulation of alpha-particle-emitting 225Ac3 + ions within carbon nanotubes. J. Nucl. Med. 56, 897–900 (2015)
B.T. Cisneros, J.J. Law, M.L. Matson, A. Azhdarinia, E.M. Sevick-Muraca, L.J. Wilson, Stable confinement of positron emission tomography and magnetic resonance agents within carbon nanotubes for bimodal imaging. Nanomedicine (London) 9, 2499–2509 (2014)
G. Chen, H. Qiu, P.N. Prasad, X. Chen, Upconversion nanoparticles: design, nanochemistry, and applications in theranostics. Chem. Rev. 114, 5161–5214 (2014)
F. Auzel, Upconversion and anti-Stokes processes with f and d ions in solids. Chem. Rev. 104, 139–173 (2004)
J. Shen, L. Zhao, G. Han, Lanthanide-doped upconverting luminescent nanoparticle platforms for optical imaging-guided drug delivery and therapy. Adv. Drug Deliv. Rev. 65, 744–755 (2013)
Z. Gu, L. Yan, G. Tian, S. Li, Z. Chai, Y. Zhao, Recent advances in design and fabrication of upconversion nanoparticles and their safe theranostic applications. Adv. Mater. 25, 3758–3779 (2013)
H. Xing, W. Bu, S. Zhang, X. Zheng, M. Li, F. Chen et al., Multifunctional nanoprobes for upconversion fluorescence. MR and CT trimodal imaging. Biomaterials 33, 1079–1089 (2012)
Y. Yang, Y. Sun, T. Cao, J. Peng, Y. Liu, Y. Wu et al., Hydrothermal synthesis of NaLuF4:153Sm, Yb, Tm nanoparticles and their application in dual-modality upconversion luminescence and SPECT bioimaging. Biomaterials 34, 774–783 (2013)
Y. Sun, M. Yu, S. Liang, Y. Zhang, C. Li, T. Mou et al., Fluorine-18 labeled rare-earth nanoparticles for positron emission tomography (PET) imaging of sentinel lymph node. Biomaterials 32, 2999–3007 (2011)
J. Gallo, I.S. Alam, J. Jin, Y.-J. Gu, E.O. Aboagye, W.-T. Wong et al., PET imaging with multimodal upconversion nanoparticles. Dalton Trans. 43, 5535–5545 (2014)
H.J. Seo, S.H. Nam, H.-J. Im, J.-Y. Park, J.Y. Lee, B. Yoo et al., Rapid hepatobiliary excretion of micelle-encapsulated/radiolabeled upconverting nanoparticles as an integrated form. Sci Rep. 5, 15685 (2015)
J. Lee, T.S. Lee, J. Ryu, S. Hong, M. Kang, K. Im et al., RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis. J. Nucl. Med. 54, 96–103 (2013)
T. Cao, Y. Yang, Y. Sun, Y. Wu, Y. Gao, W. Feng et al., Biodistribution of sub-10 nm PEG-modified radioactive/upconversion nanoparticles. Biomaterials 34, 7127–7134 (2013)
Q. Liu, M. Chen, Y. Sun, G. Chen, T. Yang, Y. Gao et al., Multifunctional rare-earth self-assembled nanosystem for tri-modal upconversion luminescence/fluorescence/positron emission tomography imaging. Biomaterials 32, 8243–8253 (2011)
J. Rieffel, F. Chen, J. Kim, G. Chen, W. Shao, S. Shao et al., Hexamodal imaging with porphyrin-phospholipid-coated upconversion nanoparticles. Adv. Mater. 27, 1785–1790 (2015)
L. Wang, Synthetic methods of CuS nanoparticles and their applications for imaging and cancer therapy. RSC Adv. 6, 82596–82615 (2016)
S. Goel, F. Chen, W. Cai, Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics. Small 10, 631–645 (2014)
R. Chakravarty, S. Chakraborty, R.S. Ningthoujam, K.V. Vimalnath Nair, K.S. Sharma, A. Ballal et al., Industrial-scale synthesis of intrinsically radiolabeled 64CuS nanoparticles for use in positron emission tomography (PET) imaging of cancer. Ind. Eng. Chem. Res. 55, 12407–12419 (2016)
M. Zhou, R. Zhang, M. Huang, W. Lu, S. Song, M.P. Melancon et al., A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J. Am. Chem. Soc. 132, 15351–15358 (2010)
Y. Zhang, T.R. Nayak, H. Hong, W. Cai, Biomedical applications of zinc oxide nanomaterials. Curr. Mol. Med. 13, 1633–1645 (2013)
W.-Q. Zhang, Y. Lu, T.-K. Zhang, W. Xu, M. Zhang, S.-H. Yu, Controlled synthesis and biocompatibility of water-soluble ZnO nanorods/Au nanocomposites with tunable UV and visible emission intensity. J. Phys. Chem. C 112, 19872–19877 (2008)
Y. Liu, K. Ai, Q. Yuan, L. Lu, Fluorescence-enhanced gadolinium-doped zinc oxide quantum dots for magnetic resonance and fluorescence imaging. Biomaterials 32, 1185–1192 (2011)
H. Hong, F. Wang, Y. Zhang, S.A. Graves, S.B.Z. Eddine, Y. Yang et al., Red fluorescent zinc oxide nanoparticle: A novel platform for cancer targeting. ACS Appl. Mater. 7, 3373–3381 (2015)
S.S. Chou, B. Kaehr, J. Kim, B.M. Foley, M. De, P.E. Hopkins et al., Chemically exfoliated MoS2 as near-infrared photothermal agents. Angew. Chem. Int. Ed. Engl. 52, 4160–4164 (2013)
S.S. Chou, M. De, J. Kim, S. Byun, C. Dykstra, J. Yu et al., Ligand conjugation of chemically exfoliated MoS2. J. Am. Chem. Soc. 135, 4584–4587 (2013)
L. Cheng, J. Liu, X. Gu, H. Gong, X. Shi, T. Liu et al., PEGylated WS(2) nanosheets as a multifunctional theranostic agent for in vivo dual-modal CT/photoacoustic imaging guided photothermal therapy. Adv. Mater. 26, 1886–1893 (2014)
J. Li, F. Jiang, B. Yang, X.-R. Song, Y. Liu, H.-H. Yang et al., Topological insulator bismuth selenide as a theranostic platform for simultaneous cancer imaging and therapy. Sci. Rep. 3, 1998 (2013)
L. Cheng, S. Shen, S. Shi, Y. Yi, X. Wang, G. Song et al., FeSe2-decorated Bi2Se3 nanosheets fabricated via cation exchange for chelator-free 64Cu-labeling and multimodal image-guided photothermal-radiation therapy. Adv. Funct. Mater. 26, 2185–2197 (2016)
T. Liu, S. Shi, C. Liang, S. Shen, L. Cheng, C. Wang et al., Iron oxide decorated MoS2 nanosheets with double PEGylation for chelator-free radiolabeling and multimodal imaging guided photothermal therapy. ACS Nano 9, 950–960 (2015)
F. Ai, S. Goel, Y. Zhan, H.F. Valdovinos, F. Chen, T.E. Barnhart et al., Intrinsically 89Zr-labeled Gd2O2S: Eu nanophosphors with high in vivo stability for dual-modality imaging. Am. J. Transl. Res. 8, 5591–5600 (2016)
Y. Zhan, F. Ai, F. Chen, H.F. Valdovinos, H. Orbay, H. Sun et al., Intrinsically zirconium-89 labeled Gd2O2S: Eu nanoprobes for in vivo positron emission tomography and gamma-ray-induced radioluminescence imaging. Small 12, 2872–2876 (2016)
C. Sun, G. Pratx, C.M. Carpenter, H. Liu, Z. Cheng, S. Sam Gambhir et al., Synthesis and radioluminescence of PEGylated Eu3+-doped nanophosphors as bioimaging probes. Adv. Mater. 23, H195–H199 (2011)
Y. Song, H. You, Y. Huang, M. Yang, Y. Zheng, L. Zhang et al., Highly uniform and monodisperse Gd2O2S:Ln3+ (Ln = Eu, Tb) submicrospheres: Solvothermal synthesis and luminescence properties. Inorg. Chem. 49, 11499–11504 (2010)
S.A. Osseni, S. Lechevallier, M. Verelst, P. Perriat, J. Dexpert-Ghys, D. Neumeyer et al., Gadolinium oxysulfide nanoparticles as multimodal imaging agents for T2-weighted MR{,} X-ray tomography and photoluminescence. Nanoscale 6, 555–564 (2014)
E. Morales-Avila, G. Ferro-Flores, B.E. Ocampo-García, de María Ramírez, F, Radiolabeled nanoparticles for molecular imaging, in ed. by B. Schaller (Molecular Imaging. Intech. 2012)
I. Ojea-Jimenez, J. Comenge, L. Garcia-Fernandez, Z.A. Megson, E. Casals, V.F. Puntes, Engineered inorganic nanoparticles for drug delivery applications. Curr. Drug Metab. 14, 518–530 (2013)
K. Stockhofe, J.M. Postema, H. Schieferstein, T.L. Ross, Radiolabeling of nanoparticles and polymers for PET imaging. Pharmaceuticals (Basel). 7, 392–418 (2014)
G. Ferro-Flores, B.E. Ocampo-García, C.L. Santos-Cuevas, E. Morales-Avila, E. Azorín-Vega, Multifunctional radiolabeled nanoparticles for targeted therapy. Curr. Med. Chem. 21, 124–138 (2014)
J. Xie, S. Lee, X. Chen, Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev. 62, 1064–1079 (2010)
D. Bargheer, A. Giemsa, B. Freund, M. Heine, C. Waurisch, G.M. Stachowski et al., The distribution and degradation of radiolabeled superparamagnetic iron oxide nanoparticles and quantum dots in mice. Beilstein J. Nanotechnol. 6, 111–123 (2015)
Q.K.T. Ng, C.I. Olariu, M. Yaffee, V.F. Taelman, N. Marincek, T. Krause et al., Indium-111 labeled gold nanoparticles for in-vivo molecular targeting. Biomaterials 35, 7050–7057 (2014)
M. Sun, G. Sundaresan, P. Jose, L. Yang, D. Hoffman, N. Lamichhane et al., Highly stable intrinsically radiolabeled indium-111 quantum dots with multidentate zwitterionic surface coating: dual modality tool for biological imaging. J. Mater Chem. B 2, 4456–4466 (2014)
J.D. Woodward, S.J. Kennel, S. Mirzadeh, S. Dai, J.S. Wall, T. Richey et al., In vivo SPECT/CT imaging and biodistribution using radioactive Cd125mTe/ZnS nanoparticles. Nanotechnology 18, 175103 (2007)
Acknowledgements
This work was supported, in part, by the University of Wisconsin —Madison, the National Institutes of Health (NIBIB/NCI 1R01CA169365, 1R01EB021336, P30CA014520), the American Cancer Society (125246-RSG-13-099-01-CCE) and CNPq (Brazilian National Council for Scientific and Technological Development).
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Ferreira, C.A., Goel, S., Cai, W. (2018). Exogenous Radionanomedicine: Inorganic Nanomaterials. In: Lee, D. (eds) Radionanomedicine. Biological and Medical Physics, Biomedical Engineering. Springer, Cham. https://doi.org/10.1007/978-3-319-67720-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-67720-0_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67719-4
Online ISBN: 978-3-319-67720-0
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)